Casma Therapeutics Announces $50 Million Series B Financing Portfolio News / By Karina Tin September 10, 2020 Casma Therapeutics Announces $50 Million Series B Financing Read More »
NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at The Digital International Liver Congress™ (ILC) 2020 and Announces Enrollment Completed in Phase 2b ALPINE 2/3 Study Portfolio News / By Karina Tin August 29, 2020 NGM Bio Presents Comprehensive Findings from 24-Week Phase 2 Study (Cohort 4) of Aldafermin in Oral Plenary Presentation at The Digital International Liver Congress™ (ILC) 2020 and Announces Enrollment Completed in Phase 2b ALPINE 2/3 Study Read More »
RAPT Therapeutics Reports Second Quarter 2020 Financial Results Portfolio News / By Karina Tin August 13, 2020 RAPT Therapeutics Reports Second Quarter 2020 Financial Results Read More »
NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results Portfolio News / By Karina Tin August 12, 2020 NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results Read More »
Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress Portfolio News / By Karina Tin August 10, 2020 Revolution Medicines Reports Second Quarter 2020 Financial Results and Provides Update on Corporate Progress Read More »
Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates Portfolio News / By Karina Tin August 6, 2020 Arcus Biosciences Announces Second Quarter 2020 Financial Results and Corporate Updates Read More »
Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update Portfolio News / By Karina Tin August 5, 2020 Constellation Pharmaceuticals Announces Second-Quarter 2020 Financial Results, Provides Regulatory Update Read More »
ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update Portfolio News / By Karina Tin August 5, 2020 ORIC Pharmaceuticals Reports Second Quarter 2020 Financial and Operational Update Read More »
Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing Portfolio News / By Karina Tin July 29, 2020 Nura Bio (formerly Proneurotech) Launches to Discover and Develop Neuroprotective Drugs, Backed by $73M Series A Financing Read More »
NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Portfolio News / By Karina Tin July 27, 2020 NGM Bio Announces Initiation of Phase 2 CATALINA Study of NGM621 in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) Read More »
